AstraZeneca

Immunai, AstraZeneca collaborate to optimize cancer clinical trials

Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.

Cancer (Illustrative)
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

US to move COVID-19 vaccines, treatments to private markets in 2023

AION Labs CEO Mati Gil.

AION, aMoon up for top scientific innovation award

A health worker is seen preparing to administer the a third COVID-19 booster shot (illustrative).

COVID-19 booster shots are crucial, according to a Yale study


'Our COVID vaccine as good or better than AstraZeneca's' - Valneva

A study showed that Valneva's vaccine, given in two shots 28 days apart, prompted significantly fewer adverse reactions, such as arm pain and fever.

 The logo of Valneva SE is pictured at the company's headquarters in Saint-Herblain, near Nantes, France, September 13, 2021.

COVID: Israel to give AstraZeneca vaccine to those affected by Pfizer

The country is on the cusp of 8,000 deaths since the beginning of the pandemic.

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

EU begins reviewing AstraZeneca's COVID-19 antibody cocktail

The medicine has proven to work in the non-infected and was also shown to save lives and prevent severe disease when given as treatment within a week of first symptoms.

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

COVID vaccines: Pfizer, AstraZeneca, Sputnik V more effective than Sinopharm - study

According to the study, which included the data of more than one million people, the Chinese-developed Sinopharm vaccine was less suitable for those over 50 years old.

 Vials representing the mRNA coronavirus disease (COVID-19) vaccine candidate developed by Sinopharm's China National Biotec Group (CNBG) are seen displayed at its booth at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021.

EU lists rare nerve disorder as possible side-effect of AstraZeneca COVID-19 vaccine

The European Medicines Agency also tagged some other less severe side-effects to vaccines from Johnson & Johnson, Moderna as well as AstraZeneca's shot. 

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

What you need to know about the coronavirus right now

A new variant has been detected in South Africa, the EU has vaccinated 70% of its adults, and more - here's what you need to know about COVID-19

A woman wears a protective mask during the coronavirus pandemic

Barbie debuts British COVID-19 vaccine developer doll

Gilbert, a 59-year-old professor at Oxford University and co-developer of the Oxford/AstraZeneca vaccine, is one of six women in the COVID-19 fight who have new Barbies modeled after them.

An undated handout image of a Barbie doll made in the likeness of Sarah Gilbert (3d R), the Oxford University professor who co-designed the Oxford/AstraZeneca vaccine, among a global lineup of women of healthcare sector honoured with a one-of-a-kind doll.

Combining AstraZeneca, mRNA COVID-19 vaccines 88% effective - Danish study

"The study shows that fourteen days after a combined vaccination program, the risk of infection with SARS-CoV-2 is reduced by 88% compared to unvaccinated individuals," the State Serum Institute said

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

Vietnam to mix doses of Pfizer, AstraZeneca COVID-19 vaccines

A Spanish study found the Pfizer-AstraZeneca combination was highly safe and effective, according to preliminary results.

A healthcare worker hands over doses of the Pfizer-BioNTech COVID-19 vaccine to a doctor at Messe Wien Congress Center, which has been set up as coronavirus disease vaccination centre, in Vienna, Austria February 7, 2021.

North Korea rejected AstraZeneca's COVID-19 vaccine over side effects

North Korean authorities had become concerned about the AstraZeneca vaccine after reports of rare but serious blood clotting events among some people who received it.

North Korean leader Kim Jong Un attends a ceremony to inaugurate the start of construction on the first phase of a project to eventually build 50,000 new apartments, in Pyongyang, North Korea